- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 14/58 - Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide (ANP); Cardionatrin; Cardiodilatin
Patent holdings for IPC class C07K 14/58
Total number of patents in this class: 136
10-year publication summary
|
7
|
9
|
14
|
14
|
7
|
14
|
5
|
4
|
11
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mayo Foundation for Medical Education and Research | 3102 |
27 |
| Bayer AG | 3206 |
8 |
| BioMarin Pharmaceutical Inc. | 373 |
8 |
| Daiichi Sankyo Company, Limited | 1864 |
7 |
| Hybio Pharmaceutical Co., Ltd. | 120 |
5 |
| PharmaIN Corporation | 36 |
5 |
| Ascendis Pharma Growth Disorders A/S | 44 |
5 |
| Centre National de La Recherche Scientifique | 10068 |
4 |
| Medtronic, Inc. | 9852 |
3 |
| University of South Florida | 1824 |
3 |
| Bio-Rad Pasteur | 15 |
3 |
| National Cerebral and Cardiovascular Center | 145 |
3 |
| Regeneron Pharmaceuticals, Inc. | 3978 |
3 |
| Bio Rad Europe GmbH | 140 |
3 |
| Boehringer Ingelheim International GmbH | 4756 |
2 |
| Eli Lilly and Company | 3715 |
2 |
| National University of Singapore | 2362 |
2 |
| Palatin Technologies, Inc. | 75 |
2 |
| Veterinary Diagnostics Institute, Inc. | 16 |
2 |
| Novartis AG | 11289 |
1 |
| Other owners | 38 |